系统性红斑狼疮表现的患病率及发病时间种族差异:加州狼疮监测项目
加州狼疮监测项目基于2007-2009年旧金山县724例SLE患者的回顾性数据,分析四个主要种族/族裔群体狼疮表现的差异。非洲裔、亚裔/太平洋岛民和西班牙裔患者的肾脏表现患病率及狼疮肾炎、血小板减少风险均高于白人,亚裔/太平洋岛民和西班牙裔患者抗磷脂综合征风险亦升高。
要点
- 非洲裔、亚裔/太平洋岛民和西班牙裔患者肾脏表现患病率及狼疮肾炎风险显著高于白人。
- 非洲裔患者神经系统表现患病率升高,非洲裔和亚裔/太平洋岛民血液系统表现患病率升高。
- 亚裔/太平洋岛民和西班牙裔患者抗磷脂综合征风险升高。
核心结论
- 不同种族/族裔群体间多种SLE临床表现的患病率存在显著差异。
- 非洲裔、亚裔/太平洋岛民和西班牙裔患者在SLE诊断后发生多种严重表现的风险增加。
研究设计与样本
- 基于人群的回顾性登记研究,纳入2007-2009年旧金山县724例SLE患者,重点覆盖亚裔/太平洋岛民和西班牙裔。
- 采用泊松回归计算表现患病率比(PR),校正性别、SLE诊断年龄和病程,以白人为参照。
- 采用Kaplan-Meier法和Cox比例风险回归分析严重表现的发生时间和风险比(HR)。
主要发现
- 非洲裔、亚裔/太平洋岛民和西班牙裔肾脏表现PR分别为1.74(95%CI 1.40-2.16)、1.68(95%CI 1.38-2.05)和1.35(95%CI 1.05-1.74)。
- 非洲裔神经系统表现PR为1.49(95%CI 1.12-1.98),非洲裔和亚裔/太平洋岛民血液系统表现PR分别为1.09(95%CI 1.04-1.15)和1.07(95%CI 1.01-1.13)。
- 非洲裔、亚裔/太平洋岛民和西班牙裔狼疮肾炎HR分别为2.4(95%CI 1.6-3.8)、4.3(95%CI 2.9-6.4)和2.3(95%CI 1.4-3.8)。
- 非洲裔、亚裔/太平洋岛民和西班牙裔血小板减少HR分别为2.3(95%CI 1.1-4.4)、2.3(95%CI 1.3-4.2)和2.2(95%CI 1.1-4.7)。
- 亚裔/太平洋岛民和西班牙裔抗磷脂综合征HR分别为2.5(95%CI 1.4-4.4)和2.6(95%CI 1.3-5.1)。
关键数值与推荐
- 肾脏表现患病率比:非洲裔1.74(95%CI 1.40-2.16),亚裔/太平洋岛民1.68(95%CI 1.38-2.05),西班牙裔1.35(95%CI 1.05-1.74)。
- 狼疮肾炎风险比:非洲裔2.4(95%CI 1.6-3.8),亚裔/太平洋岛民4.3(95%CI 2.9-6.4),西班牙裔2.3(95%CI 1.4-3.8)。
- 抗磷脂综合征风险比:亚裔/太平洋岛民2.5(95%CI 1.4-4.4),西班牙裔2.6(95%CI 1.3-5.1)。
临床怎么用
- 对非洲裔、亚裔/太平洋岛民和西班牙裔SLE患者应加强肾脏、血液系统和抗磷脂综合征的监测与早期干预。
- 种族/族裔背景可作为SLE严重表现风险分层的参考因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The California Lupus Surveillance Project (CLSP) is a population-based registry of individuals with systemic lupus erythematosus (SLE) residing in San Francisco County, California from 2007 to 2009, with a special focus on Asian/Pacific Islander and Hispanic patients. We used retrospective CLSP data to analyze racial and ethnic differences in lupus manifestations and in the timing and risk of developing severe manifestations. METHODS: A total of 724 patients with SLE were retrospectively identified. Prevalence ratios (PRs) of SLE manifestations were calculated using Poisson regression models stratified by race/ethnicity and adjusted for sex, age at SLE diagnosis, and disease duration. We studied onset of severe SLE manifestations after SLE diagnosis using Kaplan-Meier methods to examine time-to-event and Cox proportional hazards regression models to estimate hazard ratios (HRs). White patients were the referent group in all analyses. RESULTS: African Americans, Asian/Pacific Islanders, and Hispanic patients had increased prevalence of renal manifestations (PR 1.74 [95% confidence interval (95% CI) 1.40-2.16], PR 1.68 [95% CI 1.38-2.05], and PR 1.35 [95% CI 1.05-1.74], respectively). Furthermore, African Americans had increased prevalence of neurologic manifestations (PR 1.49 [95% CI 1.12-1.98]), and both African Americans (PR 1.09 [95% CI 1.04-1.15]) and Asian/Pacific Islanders (PR 1.07 [95% CI 1.01-1.13]) had increased prevalence of hematologic manifestations. African Americans, Asian/Pacific Islanders, and Hispanic patients, respectively, had higher risk of developing lupus nephritis (HR 2.4 [95% CI 1.6-3.8], HR 4.3 [95% CI 2.9-6.4], and HR 2.3 [95% CI 1.4-3.8]) and thrombocytopenia (HR 2.3 [95% CI 1.1-4.4], HR 2.3 [95% CI 1.3-4.2], and HR 2.2 [95% CI 1.1-4.7]). Asian/Pacific Islander and Hispanic patients had higher risk of developing antiphospholipid syndrome (HR 2.5 [95% CI 1.4-4.4] and HR 2.6 [95% CI 1.3-5.1], respectively). CONCLUSION: This is the first epidemiologic study comparing lupus manifestations among 4 major racial and ethnic groups. We found substantial differences in the prevalence of several clinical SLE manifestations among racial/ethnic groups and discovered that African Americans, Asian/Pacific Islanders, and Hispanic patients are at increased risk of developing several severe manifestations following a diagnosis of SLE.
引用
- Maningding E, Dall'Era M, Trupin L, et al. Racial and Ethnic Differences in the Prevalence and Time to Onset of Manifestations of Systemic Lupus Erythematosus: The California Lupus Surveillance Project. Arthritis Care Res (Hoboken). 2020. PMID: 31115180. doi:10.1002/acr.23887
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。